Theratechnologies Inc T.TH

Nothing

[longterm56]

A big yawn in pre-market trading. Another great achievement by the IR people. Not just anytime can keep the share price smothered after such great news. Truly amazing.

[longterm56]

Not just anyone...

[Lee430]

You would think for Thera to invest in a top tier IR firms services to fix this must be much less expensive than a depressed share price.

[SPCEO1]

Last year on the VM news, we had around 2 million shares trade pre-market and the stock was up  50%. This year, the research showed a melonoma tumor was vanquished in 21 days but the robot traders were apparently not plugged in this morning so we traded up a few pennies on 12,000 shares in the pre-market.   What a bizarre stock!  So far, none of the analysts have commented on

[PinnacleX]

Bizarre is an understatment, its unheard of. This should be double on that news alone, WTF a tumor gone using your treatment in 21 days!!!! and NOTHING!  what makes it even more so its on the NYSE and it doesnt get picked up there aswell. 

[qwerty22]

Nope, the oddest thing was the 50% rise last year. This years AACR data is not worth $450 million.

[SPCEO1]

Not yet, but it might be on the way to being worth much more than that. It was encouraging to see the details in the poster - it gave me additional confidence that they may actually have something that will work out in cancer. I am sure there will be many more twists and turns ahead as the trial proceeds but there could be a pot of gold at the end of the TH-1902 rainbow and the chances that is the

[qwerty22]

So we're heading for a 4% rise and Xbi  is again down 1.5-2%. I'm not hating today's reaction.

[Wino115]

Looks like it was dull to down everywhere. Here's what STAT news has to say on today's recap of AACR in the market: "AACR stocks to watch Monday is the day we typically turn an eye toward Wall Street to see how investors are reacting to a weekend’s worth of medical meeting news. This year, there’s not much good to look at.  Zentalis was one of the few green stocks on Monday

[Lee430]

qwerty22, Thank you for the sanity check today, it was much appeciated......except for realitycheck4u I think most of us were disapointed with todays reaction, sooooo back to waiting for the next catalyst.

[Glyndwr70]

Next catalyst ??

[SPCEO1]

Wednesday's quarterly conference call After that, we have news expected on the new version of Trogarzo coming before too much longer, although it is hard to see that as very catalyzing. At any point, the company, or the doctors involved in the TH-1902 trial as we have seen with Dr. Shah, might share information about the safety aspect of the trial.  At any time, we might hear that the

[Wino115]

Clinical data for cancer will be a step-function kind of catalyst if positive (or negative).  It will also really help their ability to pitch a convincing story. It's all reinforcing each other. 

[palinc2000]

The stock has really made a nice comeback and the upward momentum still intact .... Breaking thru 4 US and 5 Cad will add speed to the momentum.... Decent revenue growth in the first Quarter and maybe at last positive revenue guidance  for the remainder of the FY would also keep the momentum intact .... Any good news on the pipeline will of course be icing on the cake in the short term

[JayjayUSA12007]

Or it could simply be an announcement of (1) partnership in NASH or oncology programs. (2) out-licensing of some anti-cancer indications, or NASH

[FredTheVoice]

You are right JAY, The shares wont skyrock without clarification on the NASH front, I dont think even decent numbers around sales will change that at this point. Some institutions are waiting to buy more for a company in phase III in NASH, but OFFICIALLY IN PHASE III, not with only the big toe in it.... Lets see. FTV.